Carotenoid Intake and Supplementation in Cancer: Pro and Con

Carotenoids and Vitamin A in Translational Medicine

Volumn , Issue , 2013, Pages 225-258

  Siems, Werner G ^a   Sommerburg, Olaf ^b,c   Wiswedel, Ingrid ^d   Eckl, Peter M ^e   Bresgen, Nikolaus ^e   van Kuijk, Frederik J G M ^f   Crifò, Carlo ^g   Salerno, Costantino ^g  

^a KortexMed Institute of Medical Education   (Germany)

^b University Children s Hospital III   (Germany)

^c Translational Lung Research Center   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e UNIVERSITY OF SALZBURG   (Austria)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84911491918     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14569-17     Document Type: Chapter

References (204)

1. Olson JA, Krinsky NI. The colorful, fascinating world of the carotenoids: Important physiologic modulators. FASEB J 1995; 9:1547-1550.
2. Parker RS. Absorption, metabolism, and transport of carotenoids. FASEB J 1996; 10:542-551.
3. Rock CL. Carotenoids: Biology and treatment. Pharmacol Ther 1997; 75:185-197.
4. Smith W, Saba N. Retinoids as chemoprevention for head and neck cancer: Where do we go from here? Crit Rev Oncol Hematol 2005; 55:143-152.
5. Slaga TJ. Inhibition of the induction of cancer by antioxidants. Adv Exp Med Biol 1995; 369:167-174.
6. Burton GW, Ingold KU. β-Carotene: An unusual type of lipid antioxidant. Science 1984; 224:569-573.
7. Packer L. Antioxidant action of carotenoids in vitro and in vivo and protection against oxidation of human low-density lipoproteins. Ann NY Acad Sci 1993; 691:48-60.
8. Sies H, Stahl W, Sundquist AR. Antioxidant functions of vitamins. Vitamins E and C, β-carotene and other carotenoids. Ann NY Acad Sci 1992; 669:7-20.
9. Ziegler RG, Mayne ST, Swanson CA. Nutrition and lung cancer. Cancer Causes Control 1996; 7:157-177.
10. Van Poppel G, Goldbohm RA. Epidemiologic evidence for β-carotene and cancer prevention. Am J Clin Nutr 1995; 62:1393S-1402S.
11. Cooper DA, Eldridge AL, Peters JC. Dietary carotenoids and lung cancer: A review of recent research. Nutr Rev 1999; 57:133-145.
12. Lippi G, Tarther G. Tomatoes, lycopene-containing foods and cancer risk. Br J Cancer 2011; 104:1234-1235.
13. Mamede AC, Tavares SD, Abrantes AM, Trindade J, Maia JM, Botelho MF. The role of vitamins in cancer: A review. Nutr Cancer 2011; 63:479-494.
14. Greenwald P, Clifford CK, Milner JA. Diet and cancer prevention. Eur J Cancer 2001; 37:948-965.
15. Greenwald P, McDonald SS. The β-carotene story. Adv Exp Med Biol 2001; 492:219-231.
16. Wakai K, Matsuo K, Nagata C, Mizoue T, Tanaka K, Tsuji I, Sasazuki S et al. (Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan). Lung cancer risk and consumption of vegetables and fruit: An evaluation based on a systematic review of epidemiological evidence from Japan. Jpn J Clin Oncol 2011; 441:693-708.
17. Peto R, Doll R, Buckley JD, Sporn MB. Can dietary β-carotene materially reduce human cancer rates? Nature 1981; 290:201-208.
18. Li C, Ford ES, Zhao G, Balluz LS, Giles WH, Liu S. Serum alpha-carotene concentrations and risk of death among US adults. The Third National Health and Nutrition Examination Survey Follow-up Study. Arch Intern Med 2011; 171:507-515.
19. Nomura AM, Ziegler RG, Stemmermann GN, Chyou PH, Craft NE. Serum micronutrients and upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev 1997; 6:407-412.
20. Zhang X, Dai B, Zhang B, Wang Z. Vitamin A and risk of cervical cancer: A meta-analysis. Gynecol Oncol 2012; 124(2):366-373.
21. Myung SK, Ju W, Kim SC, Kim H, Korean Meta-analysis (KORMA) Study Group. Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: A meta-analysis. BJOG 2011; 118:1285-1291.
22. Story EN, Kopec RE, Schwartz SJ, Harris GK. An update on the health effects of tomato lycopene. Annu Rev Food Sci Technol 2010; 1:189-210.
23. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995; 87:1767-1776.
24. Hsing QW, Comstock GW, Abbey H, Polk BF. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst 1990; 82:941-946.
25. Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ. Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis. Cancer Res 1999; 59:1225-1230.
26. Tzonou A, Signorello LB, Lagiou P, Wuu J, Trichopoulos D, Trichopoulou A. Diet and cancer of the prostate: A case-control study in Greece. Int J Cancer 1999; 80:704-708.
27. Mills PK, Beeson WL, Philips RL, Fraser GE. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 1989; 64:598-604.
28. Vogt TM, Mayne ST, Graubard BI, Swanson CA, Sowell AL, Schoenberg JB, Swanson GM et al. Serum lycopene, other serum carotenoids, and risk of prostate cancer in US blacks and whites. Am J Epidemiol 2002; 155:1023-1032.
29. Key TJ, Appleby PN, Allen NE, Travis RC, Roddam AW, Jenab M, Egevad L et al. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European prospective investigation into cancer and nutrition study. Am J Clin Nutr 2007; 86:672-681.
30. Etminan M, Takkouche B, Caamano-Isorna F. The role of tomato products and lycopene in the prevention of prostate cancer: A meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev 2004; 13:340-345.
31. Van Patten CL, de Boer JG, Tomlinson Guns ES. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: A review of the randomized controlled trial evidence. J Urol 2008; 180:2314-2321 and (discussion) 2721-2722.
32. Ford NA, Elsen AC, Yuniga K, Lindshield BL, Erdman JW Jr. Lycopene and apo-12′-lycopenal reduce cell proliferation and alter cell cycle progression in human prostate cancer cells. Nutr Cancer 2011; 63:256-263.
33. Wu K, Erdman JW, Schwartz SJ, Platz EA, Leitzmann M, Clinton SK, DeGroff V, Willett WC, Giovannucci E. Plasma and dietary carotenoids, and the risk of prostate cancer: A nested case-control study. Cancer Epidemiol Biomarkers Prev 2004; 13:260-269.
34. Hu KQ, Liu C, Ernst H, Krinsky NI, Russell RM, Wang XD. The biochemical characterization of ferret carotene-9′, 10′-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. J Biol Chem 2006; 281:19327-19338.
35. Kopec RE, Riedl KM, Harrison EH, Curley RW Jr., Hruszkewycz DP, Clinton SK, Schwartz SJ. Identification and quantification of apo-lycopenals in fruits, vegetables, and human plasma. J Agric Food Chem 2010; 58:3290-3296.
36. Gajic M, Zaripheh S, Sun F, Erdman JW. Apo-8′-lycopenal and apo-12′-lycopenal are metabolic products of lycopene in rat liver. J Nutr 2006; 136:1552-1557.
37. Kristal AR, Till C, Platz EA, Song X, King IB, Neuhouser ML, Ambrosone CB, Thompson IM. Serum lycopene concentration and prostate cancer risk: Results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 2011; 20:638-646.
38. Giovannucci E. Commentary: Serum lycopene and prostate cancer progression: A re-consideration of findings from the prostate cancer prevention trial. Cancer Causes Control 2011; 22:1055-1059.
39. Mondul AM, Watters JL, Mannisto S, Weinstein SJ, Knyder K, Virtamo J, Albanes D. Serum retinol and risk of prostate cancer. Am J Epidemiol 2011; 173:813-821.
40. Ilic D, Forbes KM, Hassed C. Lycopene for the prevention of prostate cancer. Cochrane Database Syst Rev 2011; 11:CD008007.
41. Bjelke E. Dietary vitamin A and human lung cancer. Int J Cancer 1975; 15:561-565.
42. Ziegler RG. A review of epidemiologic evidence that carotenoids reduce the risk of cancer. J Nutr 1989; 119:116-122.
43. Gallicchio L, Boyd K, Matanoski G, Tao XG, Chen L, Lam TK, Shiels M et al. Carotenoids and the risk of developing lung cancer: A systematic review. Am J Clin Nutr 2008; 88:372-383.
44. Fritz H, Kennedy D, Fergusson D, Fernandez R, Doucette S, Cooley K, Seely A, Sagar S, Wong R, Seely D. Vitamin A and retinoid derivatives for lung cancer: A systematic review and meta analysis. PLoS One 2011; 6:e21107; 1-11.
45. Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, Albanes D, Taylor PR, Albert P; ATBC Study Group. Incidence of cancer and mortality following alpha-tocopherol and β-carotene supplementation: A postintervention follow-up. JAMA 2003; 290:476-485.
46. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330:1029-1035.
47. Zhang SM. Role of vitamins in the risk, prevention, and treatment of breast cancer. Curr Opin Obstet Gynecol 2004; 16:19-25.
48. Lazzeroni M, Gandini S, Puntoni M, Bonanni B, Gennari A, DeCensi A. The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it. Breast 2011; 20(Suppl 3):S36-S41.
49. Young AJ, Lowe GM. Antioxidant and prooxidant properties of carotenoids. Arch Biochem Biophys 2001; 385:20-27.
50. Alija AJ, Bresgen N, Sommerburg O, Siems W, Eckl PM. Cytotoxic and genotoxic effects of β-carotene breakdown products on primary rat hepatocytes. Carcinogenesis 2004; 25:827-831.
51. Siems W, Wiswedel I, Sommerburg O, Langhans CD, Salerno C, Crifò C, Capuozzo C, Alija A, Bresgen N, Eckl P. Clinical use of carotenoids-Antioxidative protection versus prooxidative side effects. In: Free Radicals and Diseases: Gene Expression, Cellular Metabolism and Pathophysiology. NATO Science Series (T Grune, ed.). IOS Press, Amsterdam, the Netherlands, 2005; pp. 177-192.
52. Alija AJ, Bresgen N, Sommerburg O, Langhans CD, Siems W, Eckl PM. Cyto- and genotoxic potential of â-carotene and cleavage products under oxidative stress. BioFactors 2005; 24:159-164.
53. Alija AJ, Bresgen N, Sommerburg O, Langhans CD, Siems W, Eckl PM. β-Carotene breakdown products enhance genotoxic effects of oxidative stress in primary rat hepatocytes. Carcinogenesis 2006; 27:1128-1133.
54. Salerno C, Capuozzo E, Crifò C, Siems W. Alpha-tocopherol increases caspase-3 up-regulation and apoptosis by β-carotene cleavage products in human neutrophils. BBA 2007; 1772:1052-1056.
55. Palozza P, Simone R, Mele MC. Interplay of carotenoids with cigarette smoking: Implications in lung cancer. Curr Med Chem 2008; 15:844-854.
56. Siems W, Salerno C, Crifò C, Sommerburg O, Wiswedel I. β-Carotene degradation products: Formation, toxicity and prevention of toxicity. In: Forum of Nutrition 61: Food Factors for Health Promotion (T Yoshikawa, Y Naito, eds.). Karger Publ. Co., Basel, Switzerland, 2009; pp. 75-86.
57. Alija A, Bresgen N, Bojaxhi E, Vogl C, Siems W, Eckl PM. Cytotoxicity of β-carotene cleavage products and its prevention by antioxidants. Acta Biochim Pol 2010; 57:217-221.
58. Edge R, Truscott TG. Prooxidant and antioxidant reaction mechanisms of carotene and radical interactions with vitamins E and C. Nutrition 1997; 13:992-994.
59. Murata M, Kawanishi S. Oxidative DNA damage by Vitamin A and its derivative via superoxide generation. J Biol Chem 2000; 275:2003-2008.
60. Siems WG, Sommerburg O, Hurst JS, van Kuijk FJGM. Carotenoid oxidative degradation products inhibit Na+-K+-ATPase. Free Radic Res 2000; 33:427-435.
61. Kowaltowski AJ, Vercesi AE. Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med 1999; 26:463-471.
62. Schild L, Keilhoff G, Augustin W, Reiser G, Striggow F. Distinct Ca2+ thresholds determine cytochrome c release or permeability transition pore opening in brain mitochondria. FASEB J 2001; 15:565-567.
63. Turrens JF. Superoxide production by the mitochondrial respiratory chain. Biosci Rep 1997; 17:3-8.
64. Siems W, Sommerburg O, Schild L, Augustin W, Langhans CD, Wiswedel I. β-Carotene cleavage products induce oxidative stress in vitro by impairing mitochondrial respiration. FASEB J 2002; 16:1289-1291.
65. Stratton SP, Schaefer WH, Liebler DC. Isolation and identification of singlet oxygen oxidation products of β-carotene. Chem Res Toxicol 1993; 6:542-547.
66. Ojima F, Sakamoto H, Ishiguro Y, Terao J. Consumption of carotenoids in photosensitized oxidation of human plasma and plasma low-density lipoprotein. Free Radic Biol Med 1993; 15:377-384.
67. Liebler DC, McClure TD. Antioxidant reactions of β-carotene: Identification of carotenoid-radical adducts. Chem Res Toxicol 1996; 9:8-11.
68. McClure TD, Liebler DC. A rapid method for profiling the products of antioxidant reactions by negative ion chemical ionization mass spectrometry. Chem Res Toxicol 1995; 8:128-135.
69. Kennedy TA, Liebler DC. Peroxyl radical oxidation of β-carotene: Formation of β-carotene epoxides. Chem Res Toxicol 1991; 4:290-295.
70. El-Tinay AH, Chichester CO. Oxidation of β-carotene. Site of initial attack. J Org Chem 1970; 35:2290-2293.
71. Handelman GJ, van Kuijk FJ, Chatterjee A, Krinsky NI. Characterization of products formed during the autoxidation of β-carotene. Free Radic Biol Med 1991; 10:427-437.
72. Henry LK, Puspitasari-Nienaber NL, Jaren-Galan M, van Breemen RB, Catignani GL, Schwartz SJ. Effects of ozone and oxygen on the degradation of carotenoids in an aqueous model system. J Agric Food Chem 2000; 48:5008-5013.
73. Sommerburg O, Langhans CD, Arnhold J, Leichsenring M, Salerno C, Crifò C, Hoffmann GF, Debatin KM, Siems WG. β-Carotene cleavage products after oxidation mediated by hypochlorous acid. A model for neutrophil-derived degradation. Free Radic Biol Med 2003; 35:1480-1490.
74. Mein JR, Dolnikowski GG, Ernst H, Russell RM, Wang XD. Enzymatic formation of apo-carotenoids from the xanthophyll carotenoids lutein, zeaxanthin and β-cryptoxanthin by ferret carotene-9′, 10′-monooxygenase. Arch Biochem Biophys 2011; 506:108-121.
75. Mordi RC, Walton JC, Burton GW, Hughes L, Ingold KU, Lindsay DA, Moffatt D. Oxidative degradation of β-carotene and β-apo-8′-carotenal. Tetrahedron 1993; 49:911-928.
76. Mordi RC, Walton JC, Burton GW, Hughes L, Ingold KU, Lindsay DA. Exploratory study of β-carotene auto-oxidation. Tetrahedron Lett 1991; 32:4203-4206.
77. Ouyang JM, Daun H, Chang SS, Ho CT. Formation of carbonyl compounds from β-carotene during palm oil deodorization. J Food Sci 1980; 45:1214-1222.
78. Marty D, Berset C. Degradation products of trans-β-carotene produced during extrusion cooking. J Food Sci 1988; 53:1880-1886.
79. Gloria MB, Grulke EA, Gray JI. Effect of type of oxidation on β-carotene loss and volatile products formation in model systems. Food Chem 1993; 46:401-406.
80. Onyewu PN, Ho CT, Daun H. Characterization of β-carotene thermal degradation products in a model food system. J Am Oil Chem Soc 1986; 63:1437-1441.
81. Schreier P, Drawert F, Bhiwapurkar S. Volatile compounds formed by thermal degradation of β-carotene. Chem Mikrobiol Technol Lebensm 1979; 6:90-91.
82. Mader I. β-Carotene: Thermal degradation. Science 1964; 144:533-534.
83. Day WC, Erdman JG. Ionene: A thermal degradation product of β-carotene. Science 1963; 141:808.
84. Zhao W, Han Y, Zhao B, Hirota S, Hou J, Xin W. Effect of carotenoids on the respiratory burst of rat peritoneal macrophages. Biochim Biophys Acta 1998; 1381:77-88.
85. Foote CS, Chang YC, Denny RW. Chemistry of singlet oxygen: Carotenoid quenching parallels biological protection. J Am Chem Soc 1970; 92:5216-5218.
86. Di Mascio P, Devasagayam TP, Kaiser S, Sies H. Carotenoids, tocopherols and thiols as biological singlet molecular oxygen quenchers. Biochem Soc Trans 1990; 18:1054-1056.
87. Conn PF, Schalch W, Truscott TG. The singlet oxygen and carotenoid interaction. J Photochem Photobiol B 1991; 11:41-47.
88. Sundquist AR, Briviba K, Sies H. Singlet oxygen quenching by carotenoids. Methods Enzymol 1994; 234:384-388.
89. Albrich JM, McCarthy CA, Hurst JK. Biological reactivity of hypochlorous acid: Implications for microbicidal mechanisms of leukocyte myeloperoxidase. Proc Natl Acad Sci U S A 1981; 78:210-214.
90. Panasenko OM, Sharov VS, Briviba K, Sies H. Interaction of peroxynitrite with carotenoids in human low density lipoproteins. Arch Biochem Biophys 2000; 373:302-305.
91. Olson JA. Molecular actions of carotenoids. Ann NY Acad Sci 1993; 691:156-166.
92. Von Lintig J, Wyss A. Molecular analysis of vitamin A formation: Cloning and characterization of ß-carotene 15, 15′-dioxygenases. Arch Biochem Biophys 2001; 385:47-52.
93. Von Lintig J, Vogt K. Filling the gap in vitamin A research. Molecular identification of an enzyme cleaving β-carotene to retinal. J Biol Chem 2000; 275:11915-11920.
94. Krinsky NI. The antioxidant and biological properties of the carotenoids. Ann NY Acad Sci 1998; 854:443-447.
95. Krinsky NI. Actions of carotenoids in biological systems. Annu Rev Nutr 1993; 13:561-587.
96. Krinsky NI. Antioxidant functions of carotenoids. Free Radic Biol Med 1989; 7:617-635.
97. Liebler DC. Antioxidant reactions of carotenoids. Ann NY Acad Sci 1993; 691:20-31.
98. Siems W, Sommerburg O, van Kuijk F. Oxidative breakdown of carotenoids and biological effects of their metabolites. In: Handbook of Antioxidants (E Cadenas, L Packer, eds.). Marcel Dekker, Inc., New York, 2001; pp. 235-249.
99. Salerno C, Crifò C, Siems W. Carotenoids and lung cancer: Biochemical aspects. Cent Eur J Chem 2011; 9:1-6.
100. Chen JJ, Bertrand H, Yu BP. Inhibition of adenine nucleotide translocator by lipid peroxidation products. Free Radic Biol Med 1995; 19:583-590.
101. Notario B, Zamora M, Vinas O, Mampel T. All-trans-retinoic acid binds to and inhibits adenine nucleotide translocase and induces mitochondrial permeability transition. Mol Pharmacol 2003; 63:224-231.
102. Korichneva I, Waka J, Hammerling U. Regulation of the cardiac mitochondrial membrane potential by retinoids. J Pharmacol Exp Ther 2003; 305:426-433.
103. Britton G. Structure and properties of carotenoids in relation to function. FASEB J 1995; 9:1551-1558.
104. Tsuchihashi H, Kigoshi M, Iwatsuki M, Niki E. Action of β-carotene as an antioxidant against lipid peroxidation. Arch Biochem Biophys 1995; 323:137-147.
105. Estornell E, Tormo JR, Marin P, Renau-Piqueras J, Timoneda J, Barber T. Effects of vitamin A deficiency on mitochondrial function in rat liver and heart. Br J Nutr 2000; 84:927-934.
106. Lotan R. Receptor-independent induction of apoptosis by synthetic retinoids. J Biol Regul Homeost Agents 2003; 17:13-28.
107. Schmitz HH, Poor CL, Wellman RB, Erdman JJ. Concentrations of selected carotenoids and vitamin A in human liver, kidney and lung tissue. J Nutr 1991; 121:1613-1621.
108. Mayne ST. β-Carotene, carotenoids, and disease prevention in humans. FASEB J 1996; 10:690-701.
109. Winterbourn CC. Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite. Biochim Biophys Acta 1985; 840:204-210.
110. Schiller J, Arnhold J, Grunder W, Arnold K. The action of hypochlorous acid on polymeric components of cartilage. Biol Chem Hoppe Seyler 1994; 375:167-172.
111. Schaur RJ, Jerlich A, Stelmaszynska T. Hypochlorous acid as reactive oxygen species. Curr Top Biophys 1998; 22:176-185.
112. Nauseef WM. Insights into myeloperoxidase biosynthesis from its inherited deficiency. J Mol Med 1998; 76:661-668.
113. Panasenko OM, Panasenko OO, Briviba K, Sies H. Hypochlorite destroys carotenoids in low density lipoproteins thus decreasing their resistance to peroxidative modification. Biochemistry (Mosc) 1997; 62:1140-1145.
114. Vogt W, Hesse D. Oxidants generated by the myeloperoxidase-halide system activate the fifth component of human complement, C5. Immunobiology 1994; 192:1-9.
115. Weiss SJ, Klein R, Slivka A, Wei M. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest 1982; 70:598-607.
116. Amin K, Ekberg-Jansson A, Lofdahl CG, Venge P. Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: A biopsy study. Thorax 2003; 58:135-142.
117. Eidelman D, Saetta MP, Ghezzo H, Wang NS, Hoidal JR, King M, Cosio MG. Cellularity of the alveolar walls in smokers and its relation to alveolar destruction. Functional implications. Am Rev Respir Dis 1990; 141:1547-1552.
118. Saetta M, Turato G, Baraldo S, Zanin A, Braccioni F, Mapp CE, Maestrelli P, Cavallesco G, Papi A, Fabbri LM. Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med 2000; 161:1016-1021.
119. Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp CE, Fabbri LM, Donner CF, Saetta M. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158:1277-1285.
120. Amin K, Ludviksdottir D, Janson C, Nettelbladt O, Bjornsson E, Roomans GM, Boman G, Seveus L, Venge P. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am J Respir Crit Care Med 2000; 162:2295-2301.
121. Andreadis AA, Hazen SL, Comhair SA, Erzurum SC. Oxidative and nitrosative events in asthma. Free Radic Biol Med 2003; 35:213-221.
122. Maddox L, Schwartz DA. The pathophysiology of asthma. Annu Rev Med 2002; 53:477-498.
123. Amin K, Ludviksdottir D, Janson C, Nettelbladt O, Gudbjornsson B, Valtysdottir S, Bjornsson E et al. Inflammation and structural changes in the airways of patients with primary Sjogren’s syndrome. Respir Med 2001; 95:904-910.
124. Hubeau C, Lorenzato M, Couetil JP, Hubert D, Dusser D, Puchelle E, Gaillard D. Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa. Clin Exp Immunol 2001; 124:69-76.
125. Hallett MB, Cole C, Dewitt S. Detection and visualization of oxidase activity in phagocytes. Methods Mol Biol 2003; 225:61-67.
126. Rojkind M, Dominguez-Rosales JA, Nieto N, Greenwel P. Role of hydrogen peroxide and oxidative stress in healing responses. Cell Mol Life Sci 2002; 59:1872-1891.
127. Reynolds PR, Cosio MG, Hoidal JR. Cigarette smoke-induced Egr-1 upregulates proinflammatory cytokines in pulmonary epithelial cells. Am J Respir Cell Mol Biol 2006; 35:314-319.
128. Smith CJ, Perfetti TA, King JA. Perspectives on pulmonary inflammation and lung cancer risk in cigarette smokers. Inhal Toxicol 2006; 18:667-677.
129. Walser T, Cui X, Yanagawa J, Lee JM, Heinrich E, Lee G, Sharma S, Dubinett SM. Smoking and lung cancer: The role of inflammation. Proc Am Thorac Soc 2008; 5:811-815.
130. Kim V, Rogers TJ, Criner GJ. New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5:478-485.
131. Baratelli F, Lin Y, Zhu L, Yang SC, Heuzé-Vourc’h N, Zeng G, Reckamp K, Dohadwala M, Sharma S, Dubinett SM. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J Immunol 2005; 175:1483-1490.
132. Leng Q, Bentwich Z, Borkow G. Increased TGF-β, Cbl-b and CTLA-4 levels and immunosuppression in association with chronic immune activation. Int Immunol 2006; 18:637-644.
133. Bainton DF, Ullyot JL, Farquhar MG. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. J Exp Med 1971; 134:907-934.
134. Jenner AM, Ruiz EJ, Dunster C, Halliwell B, Mann GE, Siow RCM. Vitamin C protects against hypochlorous acid-induced glutathione depletion and DNA base and protein damage in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2002; 22:574-580.
135. Arisawa F, Tatsuzawa H, Kambayashi Y, Kuwano H, Fujimori K, Nakano M. MCLA-dependent chemiluminescence suggests that singlet oxygen plays a pivotal role in myeloperoxidase-catalysed bactericidal action in neutrophil phagosomes. Luminescence 2003; 18:229-238.
136. Fu X, Mueller DM, Heinecke JW. Generation of intramolecular and intermolecular sulfenamides, sulfinamides, and sulfonamides by hypochlorous acid: A potential pathway for oxidative cross-linking of low-density lipoprotein by myeloperoxidase. Biochemistry 2002; 41:1293-1301.
137. Peskin AV, Winterbourn CC. Kinetics of the reactions of hypochlorous acid and amino acid chloramines with thiols, methionine, and ascorbate. Free Radic Biol Med 2001; 30:572-579.
138. Naskalski JW. Oxidative modification of protein structures under the action of myeloperoxidase and the hydrogen peroxide and chloride system. Ann Biol Clin 1994; 52:541-456.
139. Carr AC, Van den Berg JJM, Winterbourn CC. Differential reactivities of hypochlorous and hypobromous acids with purified Escherichia coli phospholipids: Formation of haloamines and halohydrins. Biochim Biophys Acta 1998; 1392:254-264.
140. Pattison DI, Hawkins CL, Davies MJ. Hypochlorous acid-mediated oxidation of lipid components and antioxidants present in low-density lipoproteins: Absolute rate constants, product analysis, and computational modelling. Chem Res Toxicol 2003; 16:439-449.
141. Hazel LJ, Davies MJ, Stocker R. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced LDL lipid peroxidation. Biochem J 1999; 339:489-495.
142. Hawkins CL, Pattison DI, Davies MJ. Reaction of protein chloramines with DNA and nucleotides: Evidence for the formation of radicals, protein-DNA cross-links and DNA fragmentation. Biochem J 2002; 365:805-615.
143. Whiteman M, Hooper DC, Scott GS, Koprowski H, Halliwell B. Inhibition of hypochlorous acid-induced cellular toxicity by nitrite. Proc Nat Acad Sci U S A 2002; 99:12061-12066.
144. Ueda T, Maekawa T, Sadamitsu D, Ohshita S, Ogino K, Nakamura K. The determination of nitrite and nitrate in human blood plasma by capillary zone. Electrophoresis 1995; 16:1002-1004.
145. Wanchu A, Agnihotri N, Deodhar SD, Ganguly NK. Plasma reactive nitrogen intermediate levels in patients with clinically active rheumatoid arthritis. Indian J Med Res 1996; 104:263-268.
146. Sud A, Khullar M, Wanchu A, Bambery P. Increased nitric oxide production in patients with systemic sclerosis. Nitric Oxide 2000; 4:615-619.
147. Wanchu A, Khullar M, Sud A, Bambery P. Elevated nitric oxide production in patients with primary Sjogren’s syndrome. Clin Rheumatol 2000; 19:360-364.
148. Wanchu A, Khullar M, Deodhar SD, Bambery P, Sud A. Nitric oxide synthesis is increased in patients with systemic lupus erythematosus. Rheumatol Int 1998; 18:41-43.
149. Panasenko OM, Briviba K, Klotz LO, Sies H. Oxidative modification and nitration of human low-density lipoproteins by the reaction of hypochlorous acid with nitrite. Arch Biochem Biophys 1997; 343:254-259.
150. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998; 391:393-397.
151. Whiteman M, Spencer JP, Jenner A, Halliwell B. Hypochlorous acid-induced DNA base modification: Potentiation by nitrite: Biomarkers of DNA damage by reactive oxygen species. Biochem Biophys Res Commun 1999; 257:572-576.
152. Whiteman M, Rose P, Halliwell B. Inhibition of hypochlorous acid-induced oxidative reactions by nitrite: Is nitrite an antioxidant? Biochem Biophys Res Commun 2003; 303:1217-1224.
153. Davies CA, Rocks SA, O’Shaughnessy MC, Perrett D, Winyard PG. Analysis of nitrite and nitrate in the study of inflammation. Methods Mol Biol 2003; 225:305-320.
154. Pagliaro P. Differential biological effects of products of nitric oxide (NO) synthase: It is not enough to say NO. Life Sci 2003; 73:2137-2149.
155. Albina JE. On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukoc Biol 1995; 58:643-649.
156. Wheeler MA, Smith SD, Garcia-Cardena G, Nathan CF, Weiss RM, Sessa WC. Bacterial infection induces nitric oxide synthase in human neutrophils. J Clin Invest 1997; 99:110-116.
157. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 1996; 271:C1424-1437.
158. Kissner R, Koppenol WH. Product distribution of peroxynitrite decay as a function of pH, temperature, and concentration. J Am Chem Soc 2002; 124:234-239.
159. Jourd’heuil D, Jourd’heuil FL, Kutchukian PS, Musah RA, Wink DA, Grisham MB. Reaction of superoxide and nitric oxide with peroxynitrite. Implications for peroxynitrite-mediated oxidation reactions in vivo. J Biol Chem 2001; 276:28799-28805.
160. Squadrito GL, Pryor WA. Oxidative chemistry of nitric oxide: The roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic Biol Med 1998; 25:392-403.
161. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996; 9:836-844.
162. Van der Vliet A, Eiserich JP, Halliwell B, Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite: A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem 1997; 272:7617-7625.
163. Parks NJ, Krohn KJ, Mathis CA, Chasko JH, Geiger KR, Gregor ME, Peek NF. Nitrogen-13-labeled nitrite and nitrate: Distribution and metabolism after intratracheal administration. Science 1981; 212:58-60.
164. Radi R. Reactions of nitric oxide with metalloproteins. Chem Res Toxicol 1996; 9:828-835.
165. Siems W, Capuozzo E, Crifò C, Sommerburg O, Langhans CD, Schlipalius L, Wiswedel I, Kraemer K, Salerno C. Carotenoid cleavage products modify respiratory burst and induce apoptosis of human neutrophils. Biochim Biophys Acta 2003; 1639:27-33.
166. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407:770-776.
167. Müller K, Carpenter KL, Challis IR, Skepper JN, Arends MJ. Carotenoids induce apoptosis in the T-lymphoblast cell line Jurkat E6.1. Free Radic Res 2002; 36:791-802.
168. Robinson KM, Morre JT, Beckman JS. Triuret: A novel product of peroxynitrite-mediated oxidation of urate. Arch Biochem Biophys 2004; 423:213-217.
169. Spitsin SV, Scott GS, Mikheeva T, Zborek A, Kean RB, Brimer CM, Koprowski H, Hooper DC. Comparison of uric acid and ascorbic acid in protection against EAE. Free Radic Biol Med 2002; 33:1363-1371.
170. Böhm F, Edge R, McGarvey DJ, Truscott TG. β-Carotene with vitamins E and C offers synergistic cell protection against NOx. FEBS Lett 1998; 436:387-389.
171. Lowe GM, Booth LA, Young AJ, Bilton RF. Lycopene and β-carotene protect against oxidative damage in HT29 cells at low concentrations but rapidly lose this capacity at higher doses. Free Radic Res 1999; 30:141-151.
172. Konta T, Xu Q, Furusu A, Nakayama K, Kitamura M. Selective roles of retinoic acid receptor and retinoid X receptor in the suppression of apoptosis by all-trans-retinoic acid. J Biol Chem 2001; 276:12697-12701.
173. Cacciola SA, Cohen LA, Kashfi K. Lycopene inhibits proliferation and regulates cyclooxygenase-2 gene expression in neoplastic rat mammary epithelial cells. FASEB J 1999; 13:A551.
174. Muto Y, Fujii J, Shidoji Y, Moriwaki H, Kawaguchi T, Noda T. Growth-retardation in human cervical dysplasia-derived cell lines by β-carotene through down-regulation of epidermal growth-factor receptor. Am J Clin Nutr 1995; 62:S1535-S1540.
175. Glaves D. Role of polymorphonuclear leukocytes in the pulmonary clearance of arrested cancer cells. Invas Metast 1983; 3:160-173.
176. Chen YL, Wang JY, Chen SH, Yang BC. Granulocytes mediates the Fas-L-associated apoptosis during lung metastasis of melanoma that determines the metastatic behaviour. Br J Cancer 2002; 87:359-365
177. Beyer P, Al Babili S, Ye X, Lucca P, Schaub P, Welsch R, Potrykus I. Golden Rice: Introducing the β-carotene biosynthesis pathway into rice endosperm by genetic engineering to defeat vitamin A deficiency. J Nutr 2002; 132:506S-510S.
178. Potrykus I. Golden rice and beyond. Plant Physiol 2001; 125:1157-1161.
179. Hoa TT, Al Babili S, Schaub P, Potrykus I, Beyer P. Golden indica and japonica rice lines amenable to deregulation. Plant Physiol 2003; 133:161-169.
180. Leonard PJ, Doyle E, Harrington W. Levels of vitamin E in the plasma of newborn infants and of the mothers. Am J Clin Nutr 1972; 25:480-484.
181. Mino M, Nishino H. Fetal and maternal relationship in serum vitamin E level. J Nutr Sci Vitaminol (Tokyo) 1973; 19:475-482.
182. Ostrea EM Jr., Balun JE, Winkler R, Porter T. Influence of breast-feeding on the restoration of the low serum concentration of vitamin E and β-carotene in the newborn infant. Am J Obstet Gynecol 1986; 154:1014-1017.
183. Oostenbrug GS, Mensink RP, Al MD, van Houwelingen A, Hornstra G. Maternal and neonatal plasma antioxidant levels in normal pregnancy, and the relationship with fatty acid unsaturation. Br J Nutr 1998; 80:67-73.
184. Kiely M, Cogan PF, Kearney PJ, Morrissey PA. Concentrations of tocopherols and carotenoids in maternal and cord blood plasma. Eur J Clin Nutr 1999; 53:711-715.
185. Khachik F, Spangler CJ, Smith JJ, Canfield LM, Steck A, Pfander H. Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. Anal Chem 1997; 69:1873-1881.
186. Sommerburg O, Meissner K, Nelle M, Lenhartz H, Leichsenring M. Carotenoid supply in breast-fed and formula-fed neonates. Eur J Pediatr 2000; 159:86-90.
187. Johnson EJ, Qin J, Krinsky NI, Russell RM. β-Carotene isomers in human serum, breast milk and buccal mucosa cells after continuous oral doses of all-trans and 9-cis β-carotene. J Nutr 1997; 127:1993-1999.
188. Canfield LM, Giuliano AR, Neilson EM, Blashil BM, Graver EJ, Yap HH. Kinetics of the response of milk and serum β-carotene to daily β-carotene supplementation in healthy, lactating women. Am J Clin Nutr 1998; 67:276-283.
189. Benabdeslam H, Abidi H, Garcia I, Bellon G, Gilly R, Revol A. Lipid peroxidation and antioxidant defenses in cystic fibrosis patients. Clin Chem Lab Med 1999; 37:511-516.
190. Portal BC, Richard MJ, Faure HS, Hadjian AJ, Favier AE. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1995; 61:843-847.
191. Rust P, Eichler I, Renner S, Elmadfa I. Effects of long-term oral β-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. Int J Vitam Nutr Res 1998; 68:83-87.
192. Winklhofer-Roob BM, van’t Hof MA, Shmerling DH. Response to oral β-carotene supplementation in patients with cystic fibrosis: A 16-month follow-up study [published erratum in Acta Paediatr 1996; 85:124]. Acta Paediatr 1995; 84:1132-1136.
193. Cobanoglu N, Ozcelik U, Gocmen A, Kiper N, Dogru D. Antioxidant effect of β-carotene in cystic fibrosis and bronchiectasis: Clinical and laboratory parameters of a pilot study. Acta Paediatr 2002; 91:793-798.
194. Wood LG, Fitzgerald DA, Lee AK, Garg ML. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am J Clin Nutr 2003; 77:150-159.
195. Renner S, Rath R, Rust P, Lehr S, Frischer T, Elmadfa I, Eichler I. Effects of β-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax 2001; 56:48-52.
196. Barber T, Borras E, Torres L, Garcia C, Cabezuelo F, Lloret A, Pallordo FV, Vina JR. Vitamin A deficiency causes oxidative damage to liver mitochondria in rats. Free Radic Biol Med 2000; 29:1-7.
197. Siems W, Wiswedel I, Salerno C, Crifò C, Augustin W, Schild L, Langhans CD, Sommerburg O. Beta-carotene breakdown products may impair mitochondrial functions-Potential side effects of high-dose beta-carotene supplementation. J Nutr Biochem 2005; 16:385-397.
198. Zheng A, Mäntymaa P, Säily M, Siitonen T, Savolainen ER, Koistinen P. An association between mitochondrial function and all-trans retinoic acid-induced apoptosis in acute myeloblastic leukaemia cells. Br J Haematol 1999; 105:215-224.
199. Hail N Jr., Youssef EM, Lotan R. Evidence supporting a role for mitochondrial respiration in apoptosis induction by the synthetic retinoid CD437. Cancer Res 2001; 61:6698-6702.
200. Hurst JS, Saini MK, Jin GF, Awasthi YC, van Kuijk FJ. Toxicity of oxidized beta-carotene to cultured human cells. Exp Eye Res 2005; 81:239-243.
201. De Oliveira MR, Moreira JC. Acute and chronic vitamin A supplementation at therapeutic doses induces oxidative stress in submitochondrial particles isolated from cerebral cortex and cerebellum of adult rats. Toxicol Lett 2007; 173:145-150.
202. De Oliveira MR, Oliveira MW, Lorenzi R, Fagundes da Rocha R, Fonseca Moreira JC. Short-term vitamin A supplementation at therapeutic doses induces a pro-oxidative state in the hepatic environment and facilitates calcium-ion-induced oxidative stress in rat liver mitochondria independently from permeability transition pore formation: Detrimental effects of vitamin A supplementation on rat liver redox and bioenergetic states homeostasis. Cell Biol Toxicol 2009; 25:545-560.
203. Maeda A, Maeda T, Golczak M, Chou S, Desai A, Hoppel CL, Matsuyama S, Palczewski K. Involvement of all-trans-retinal in acute light-induced retinopathy of mice. J Biol Chem 2009; 284:15173-15183.
204. Signorile A, Sardaro N, De Rasmo D, Scacco S, Papa F, Borracci P, Carratu MR, Papa S. Rat embryo exposure to all-trans retinoic acid results in postnatal oxidative damage of respiratory complex I in the cerebellum. Mol Pharmacol 2011; 80:704-713.